Collection of Coronavirus COVID-19 Outbreak Samples in New South Wales

  • STATUS
    Recruiting
  • End date
    Jun 30, 2021
  • participants needed
    200
  • sponsor
    Kirby Institute
Updated on 17 June 2020
Investigator
Rowena Bull
Primary Contact
Royal North Shore Hospital (4.8 mi away) Contact
+8 other location
covid-19
SARS
coronavirus infection

Summary

The objectives of this study are to characterise immune responses in people with CoV-SARS-2 infection and use this knowledge to advance vaccine design, treatment options, and diagnostic reagents. Eligible participants will include people diagnosed with SARS-CoV-2 infection, and may include recently returned travellers and non-travellers in the community presenting to tertiary hospital healthcare facilities. Recruitment will be opportunistic, and sampling intensity may vary depending on the phase of the outbreak. Participants can be enrolled at any timepoint (up to 6 months) following diagnosis of SARS-CoV-2 infection (COVID-19). Blood samples and clinical data will be collected.

Details
Treatment Biological sample and clinical data collection
Clinical Study IdentifierNCT04383652
SponsorKirby Institute
Last Modified on17 June 2020

Adding a note
adding personal notes guide

Select a piece of text and start making personal notes.

Eligibility

Yes No Not Sure

Inclusion Criteria

Gender: Male or Female
Do you have any of these conditions: Pathogen Infection Covid-19 Infection or *COVID-19 Infection or SARS-CoV-2 (COVID-19) Infection or Severe Coronavirus Disease (COVID-19) or Covid-19 o...?
Main cohort
Diagnosed with CoV-SARS-2 infection
16 years of age or older
Have provided informed consent Paediatric cohort
Diagnosed with CoV-SARS-2 infection
Less than 16 years of age
Informed consent provided by parent or caregiver

Exclusion Criteria

Main cohort
15 years of age or younger
Inability or unwillingness to provide informed consent or abide by the requirements of the study Paediatric cohort
16 years of age or older
Inability or unwillingness of parent or caregiver to provide informed consent or abide by the requirements of the study -
Clear my responses

How to participate?

Step 1 Connect with a site
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar
Name

Primary Contact

site
Name

Phone Email

0/250
Please verify that you are not a bot.
Step 2 Get screened

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more
Step 3 Enroll in the clinical study

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more
Step 4 Get your study results

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

Study

user name

Annotated by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No made yet